1 / 23

Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA

Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA. E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor. Dep. of Gastroenterology & Hepatology, Dep.of Pathology Tel-Aviv Sourasky Medical Center. Introduction. Significant increase in detection due

ofeliah
Download Presentation

Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Differential Diagnosis of Neoplastic Pancreatic Cysts:The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of Gastroenterology & Hepatology, Dep.of Pathology Tel-Aviv Sourasky Medical Center

  2. Introduction • Significant increase in detection due to widespread use of US,CT • Most lesions detected incidentally • The prevalence of pancreatic cyst is … • Cystic lesions constitute about 10 % of pancreatic tumors

  3. Clinical Presentation Most areasymptomatic • Lesion with malignant potential – 42% • Ca in situ / invasive cancer – 17% Fernandez Del Castillo et al. Arch Surg 2003

  4. Classification • Non neoplastic (pseudocysts) • Neoplastic • Non Mucinous • Serous cystadenoma • Cystic endocrine tumors • Others • Mucinous • Mucinous cystadenoma • Malignant mucinous cystic tumors • Intraductal papillary mucinous neoplasms - IPMN

  5. AIM • To describe a single center experience with EUS guided FNA in cystic pancreatic lesions • To determine the ability of EUS guided FNA to differentiate between serous and mucinous cystic tumors

  6. Methods

  7. Methods • Retrospective study • 170 patients between 1997-2006 • 155 patients ,195 EUS exams • 40 patients – EUSx2

  8. Methods • Demographic data • Clinical presentation • Imaging – US, CT , EUS • FNA • Surgical findings • Follow up on all patients (office visits , data from family physicians, gastroenterologists, patient’s families)

  9. Methods EUS • Cyst location, size, morphology • FNA – fluid: - characteristics - cytology - tumor markers –CEA,CA19-9,CA72-4,MCA • Cyst wall sampling (cell block)

  10. Results

  11. Results 101 women, 54 men Mean age – 64.3±14 years

  12. Results

  13. Results

  14. EUS-FNA vs. Surgical biopsy • 32 patients had both FNA and surgical biopsy. • The agreement rate was 66% of the cases regarding mucinous vs. non-mucinous with kappa=0.33. • Sensitivity and specificity of FNA are 59% and 80% respectively.

  15. Results • Mean of Ln(CEA)* levels were 2.6 and 5.8 for non mucinous and mucinous cases respectively (p<0.0001) • No statistically significant difference with all the other tumor markers tested • Rate of solid component in cyst – the difference was not statistically significant (p=0.14) • No difference concerning cyst size or morphology *CEA is highly skewed distributed and therefore we transformed the CEA level to Ln(CEA)

  16. BoxPlot Ln(CEA) Non-mucinous Mucinous

  17. ROC of CEA classification of Mucinous vs. Serous A Threshold of CEA=58 ng/ml yields 86.4% and 87.5% sensitivity and specificity respectively sensitivity 1-specificity AUC=0.902 (CI=(0.79-1.0))

  18. Conclusions • EUS is a useful tool but it can not alone distinguish between cystic lesions with variable malignant potential • EUS-FNA alone is also limited in its ability to correctly diagnose a cystic lesion – sensitivity 59% specificity 80% • Combination of parameters – cytology and CEA levels can significantly increase the diagnostic yield

  19. Thank You

  20. Criteria used in our Institute for Dx of Serous cysts • Clinical • Microcystic morphology • CEA level < 5 ng / ml • Histology- cuboidal, non secreting cells

  21. Criteria used in our Institute for Dx of Mucinous cysts • Clinical • Morphology – unilocular, thick septa, solid component • High viscosity (mucinous) fluid • CEA - >140 ng/ml • Histology – columnar secreting epithelium

  22. Treatment • Serous cyst - follow up only • Mucinous cyst – surgery • Diagnosis indeterminate - surgery

More Related